A phase II trial of carboplatin for intraocular retinoblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II trial of carboplatin for intraocular retinoblastoma

Published:2007 Issue:5 Volume:49 Page:643-648
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Dunkel Ira J.,Lee Thomas C.,Shi Weiji,Beaverson Katherine L.,Novetsky Danielle,Lyden David,Finlay Jonathan L.,McCormick Beryl,Abramson David H.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference18 articles.

1. Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma

2. Risk of New Cancers After Radiotherapy in Long-Term Survivors of Retinoblastoma: An Extended Follow-Up

3. Results of Combined Chemotherapy and Radiotherapy for Advanced Intraocular Retinoblastoma

4. Chemotherapy Plus Local Treatment in the Management of Intraocular Retinoblastoma

5. Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without Radiotherapy

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How we approach conservative treatment of retinoblastoma in South America in the era of local ocular treatments: A consensus of the Grupo America Latina de Oncologia Pediatrica (GALOP);Pediatric Blood & Cancer;2023-04-14

2. Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class—A Meta-Analysis;Cancers;2021-05-06

3. Response criteria for intraocular retinoblastoma: RB‐RECIST;Pediatric Blood & Cancer;2021-02-23

4. Superselective intra-arterial chemotherapy treatment for retinoblastoma: clinical experience from a tertiary referral centre;Canadian Journal of Ophthalmology;2020-10

5. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer;Cochrane Database of Systematic Reviews;2019-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3